theme,sub_theme,topic,geography_type,geography,metric,sex,age,stratum,year,date,metric_value,in_reporting_delay_period
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2025,2025-08-01,2.0600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2025,2025-08-01,0.5300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2025,2025-08-01,30.9900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2025,2025-08-01,47.3000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2025,2025-08-01,16.6800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2025,2025-08-01,15.0600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2025,2025-08-01,25.1500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2025,2025-07-01,1.7400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2025,2025-07-01,0.6100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2025,2025-07-01,30.0500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2025,2025-07-01,46.8300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2025,2025-07-01,15.4500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2025,2025-07-01,14.2500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2025,2025-07-01,26.0800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2025,2025-06-01,2.1200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2025,2025-06-01,0.6700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2025,2025-06-01,29.3100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2025,2025-06-01,46.0100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2025,2025-06-01,15.2300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2025,2025-06-01,13.8600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2025,2025-06-01,25.6700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2025,2025-05-01,2.1200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2025,2025-05-01,0.4900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2025,2025-05-01,29.1500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2025,2025-05-01,43.5700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2025,2025-05-01,14.9600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2025,2025-05-01,13.9800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2025,2025-05-01,26.3900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2025,2025-04-01,2.3000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2025,2025-04-01,0.6300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2025,2025-04-01,29.4200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2025,2025-04-01,43.2000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2025,2025-04-01,15.4100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2025,2025-04-01,15.4000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2025,2025-04-01,25.9500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2025,2025-03-01,2.6500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2025,2025-03-01,0.5400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2025,2025-03-01,29.8900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2025,2025-03-01,43.9700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2025,2025-03-01,16.4900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2025,2025-03-01,16.5500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2025,2025-03-01,25.5000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2025,2025-02-01,2.8000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2025,2025-02-01,0.7300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2025,2025-02-01,29.3900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2025,2025-02-01,45.6200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2025,2025-02-01,16.0100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2025,2025-02-01,16.8600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2025,2025-02-01,26.1000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2025,2025-01-01,2.5800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2025,2025-01-01,0.7800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2025,2025-01-01,27.2600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2025,2025-01-01,45.3900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2025,2025-01-01,14.8700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2025,2025-01-01,16.3600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2025,2025-01-01,25.0900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2024,2024-12-01,2.7000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2024,2024-12-01,0.8500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2024,2024-12-01,27.2700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2024,2024-12-01,42.6100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2024,2024-12-01,13.5700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2024,2024-12-01,15.9000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2024,2024-12-01,26.4200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2024,2024-11-01,2.4400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2024,2024-11-01,0.7400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2024,2024-11-01,26.4000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2024,2024-11-01,41.3100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2024,2024-11-01,13.8000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2024,2024-11-01,14.6300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2024,2024-11-01,24.6600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2024,2024-10-01,2.5800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2024,2024-10-01,0.3900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2024,2024-10-01,27.9500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2024,2024-10-01,40.0700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2024,2024-10-01,15.3700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2024,2024-10-01,14.7800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2024,2024-10-01,25.2300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2024,2024-09-01,2.7500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2024,2024-09-01,0.2300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2024,2024-09-01,28.6100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2024,2024-09-01,41.3900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2024,2024-09-01,17.5100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2024,2024-09-01,14.4500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2024,2024-09-01,26.2400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2024,2024-08-01,3.1400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2024,2024-08-01,0.3000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2024,2024-08-01,30.1700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2024,2024-08-01,43.3600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2024,2024-08-01,18.0100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2024,2024-08-01,15.8700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2024,2024-08-01,26.8100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2024,2024-07-01,4.2600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2024,2024-07-01,0.5300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2024,2024-07-01,31.1100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2024,2024-07-01,46.8300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2024,2024-07-01,18.3000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2024,2024-07-01,16.5900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2024,2024-07-01,28.8400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2024,2024-06-01,3.9700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2024,2024-06-01,0.9100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2024,2024-06-01,30.4500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2024,2024-06-01,46.1000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2024,2024-06-01,16.9600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2024,2024-06-01,16.9500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2024,2024-06-01,28.0900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2024,2024-05-01,3.9600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2024,2024-05-01,0.7000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2024,2024-05-01,30.0700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2024,2024-05-01,44.6700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2024,2024-05-01,17.5000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2024,2024-05-01,15.4300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2024,2024-05-01,27.4600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2024,2024-04-01,3.2000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2024,2024-04-01,0.5000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2024,2024-04-01,29.8700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2024,2024-04-01,41.5900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2024,2024-04-01,17.4000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2024,2024-04-01,13.7300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2024,2024-04-01,25.9400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2024,2024-03-01,3.1900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2024,2024-03-01,0.3400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2024,2024-03-01,30.5300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2024,2024-03-01,42.6000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2024,2024-03-01,18.6500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2024,2024-03-01,13.3100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2024,2024-03-01,25.2900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2024,2024-02-01,3.2000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2024,2024-02-01,0.5200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2024,2024-02-01,29.6600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2024,2024-02-01,43.1700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2024,2024-02-01,18.2400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2024,2024-02-01,13.3100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2024,2024-02-01,24.6200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2024,2024-01-01,3.2500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2024,2024-01-01,0.8100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2024,2024-01-01,28.2100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2024,2024-01-01,43.9600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2024,2024-01-01,17.8100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2024,2024-01-01,15.4100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2024,2024-01-01,23.4700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2023,2023-12-01,3.0800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2023,2023-12-01,0.8200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2023,2023-12-01,27.3600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2023,2023-12-01,42.4300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2023,2023-12-01,15.9700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2023,2023-12-01,16.1400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2023,2023-12-01,22.7900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2023,2023-11-01,3.7200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2023,2023-11-01,0.8000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2023,2023-11-01,28.7300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2023,2023-11-01,43.5900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2023,2023-11-01,15.8300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2023,2023-11-01,18.3900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2023,2023-11-01,25.0200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2023,2023-10-01,3.8300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2023,2023-10-01,0.8500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2023,2023-10-01,29.1400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2023,2023-10-01,42.6100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2023,2023-10-01,16.4200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2023,2023-10-01,17.2900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2023,2023-10-01,25.6700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2023,2023-09-01,3.7700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2023,2023-09-01,0.6800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2023,2023-09-01,28.2800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2023,2023-09-01,41.4300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2023,2023-09-01,16.2500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2023,2023-09-01,15.0200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2023,2023-09-01,25.4800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2023,2023-08-01,3.7000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2023,2023-08-01,1.0300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2023,2023-08-01,27.6700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2023,2023-08-01,42.7200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2023,2023-08-01,16.6100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2023,2023-08-01,14.9200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2023,2023-08-01,24.7500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2023,2023-07-01,3.7100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2023,2023-07-01,0.7100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2023,2023-07-01,28.9400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2023,2023-07-01,43.5200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2023,2023-07-01,16.9200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2023,2023-07-01,15.2800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2023,2023-07-01,25.4300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2023,2023-06-01,4.2600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2023,2023-06-01,0.8300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2023,2023-06-01,30.1500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2023,2023-06-01,45.9300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2023,2023-06-01,18.2200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2023,2023-06-01,17.0500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2023,2023-06-01,26.0700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2023,2023-05-01,4.1600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2023,2023-05-01,0.3800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2023,2023-05-01,29.2600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2023,2023-05-01,45.3700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2023,2023-05-01,19.0200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2023,2023-05-01,15.9700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2023,2023-05-01,26.2200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2023,2023-04-01,4.8200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2023,2023-04-01,0.8800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2023,2023-04-01,28.6700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2023,2023-04-01,45.3600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2023,2023-04-01,17.6900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2023,2023-04-01,16.5000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2023,2023-04-01,26.5400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2023,2023-03-01,3.8600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2023,2023-03-01,0.9900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2023,2023-03-01,27.1300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2023,2023-03-01,45.9200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2023,2023-03-01,16.2100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2023,2023-03-01,15.3600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2023,2023-03-01,24.7100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2023,2023-02-01,3.7200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2023,2023-02-01,1.0400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2023,2023-02-01,28.2800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2023,2023-02-01,44.8600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2023,2023-02-01,14.7400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2023,2023-02-01,15.3100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2023,2023-02-01,24.0000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2023,2023-01-01,3.4300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2023,2023-01-01,0.5900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2023,2023-01-01,27.7600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2023,2023-01-01,44.9400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2023,2023-01-01,13.9900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2023,2023-01-01,12.9900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2023,2023-01-01,23.1400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2022,2022-12-01,3.7900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2022,2022-12-01,0.3900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2022,2022-12-01,28.2700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2022,2022-12-01,43.3800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2022,2022-12-01,14.0400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2022,2022-12-01,12.1600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2022,2022-12-01,23.0300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2022,2022-11-01,3.1500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2022,2022-11-01,0.2800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2022,2022-11-01,26.9200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2022,2022-11-01,42.8700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2022,2022-11-01,12.6000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2022,2022-11-01,11.7300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2022,2022-11-01,21.8500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2022,2022-10-01,2.7100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2022,2022-10-01,0.2800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2022,2022-10-01,26.5000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2022,2022-10-01,43.2000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2022,2022-10-01,13.2600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2022,2022-10-01,11.7200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2022,2022-10-01,20.0900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2022,2022-09-01,2.3200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2022,2022-09-01,0.2700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2022,2022-09-01,27.0500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2022,2022-09-01,45.5400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2022,2022-09-01,13.7900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2022,2022-09-01,11.7900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2022,2022-09-01,21.7500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2022,2022-08-01,2.2600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2022,2022-08-01,0.2900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2022,2022-08-01,29.1000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2022,2022-08-01,45.6200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2022,2022-08-01,15.5300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2022,2022-08-01,10.9100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2022,2022-08-01,22.3600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2022,2022-07-01,1.5100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2022,2022-07-01,0.2000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2022,2022-07-01,28.7500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2022,2022-07-01,46.2300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2022,2022-07-01,15.0600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2022,2022-07-01,10.3000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2022,2022-07-01,22.5000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2022,2022-06-01,1.5100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2022,2022-06-01,0.0000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2022,2022-06-01,28.9000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2022,2022-06-01,45.9200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2022,2022-06-01,14.5600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2022,2022-06-01,11.1800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2022,2022-06-01,22.0500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2022,2022-05-01,2.0500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2022,2022-05-01,0.0000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2022,2022-05-01,27.9800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2022,2022-05-01,45.3900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2022,2022-05-01,14.4600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2022,2022-05-01,12.5500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2022,2022-05-01,21.4300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2022,2022-04-01,2.8200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2022,2022-04-01,0.2100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2022,2022-04-01,28.7200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2022,2022-04-01,42.5300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2022,2022-04-01,15.2500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2022,2022-04-01,13.3100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2022,2022-04-01,21.2800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2022,2022-03-01,3.0300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2022,2022-03-01,0.5200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2022,2022-03-01,27.7800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2022,2022-03-01,43.2200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2022,2022-03-01,16.1200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2022,2022-03-01,12.7900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2022,2022-03-01,20.3300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2022,2022-02-01,2.6600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2022,2022-02-01,0.8900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2022,2022-02-01,26.4500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2022,2022-02-01,43.8200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2022,2022-02-01,16.1100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2022,2022-02-01,12.4900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2022,2022-02-01,19.3100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2022,2022-01-01,2.5400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2022,2022-01-01,1.0500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2022,2022-01-01,28.2400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2022,2022-01-01,46.6700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2022,2022-01-01,16.7000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2022,2022-01-01,13.1800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2022,2022-01-01,21.1200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2021,2021-12-01,2.5200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2021,2021-12-01,0.8200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2021,2021-12-01,28.0000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2021,2021-12-01,44.4400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2021,2021-12-01,16.6500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2021,2021-12-01,13.4400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2021,2021-12-01,21.2900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2021,2021-11-01,2.0500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2021,2021-11-01,0.4700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2021,2021-11-01,27.8400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2021,2021-11-01,45.6100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2021,2021-11-01,15.9500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2021,2021-11-01,13.5300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2021,2021-11-01,20.8200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2021,2021-10-01,1.4400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2021,2021-10-01,0.3000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2021,2021-10-01,25.9300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2021,2021-10-01,44.3200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2021,2021-10-01,15.8500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2021,2021-10-01,12.7800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2021,2021-10-01,20.0200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2021,2021-09-01,1.4200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2021,2021-09-01,0.3900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2021,2021-09-01,25.4300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2021,2021-09-01,45.3300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2021,2021-09-01,14.9400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2021,2021-09-01,13.8400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2021,2021-09-01,19.9000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2021,2021-08-01,1.8200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2021,2021-08-01,0.4000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2021,2021-08-01,25.0000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2021,2021-08-01,43.1500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2021,2021-08-01,14.7800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2021,2021-08-01,12.2300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2021,2021-08-01,20.9800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2021,2021-07-01,1.9700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2021,2021-07-01,0.3000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2021,2021-07-01,26.5800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2021,2021-07-01,43.9100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2021,2021-07-01,14.5500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2021,2021-07-01,11.6900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2021,2021-07-01,21.5800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2021,2021-06-01,1.7900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2021,2021-06-01,0.2100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2021,2021-06-01,25.8500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2021,2021-06-01,41.2600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2021,2021-06-01,14.5200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2021,2021-06-01,9.8500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2021,2021-06-01,20.9200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2021,2021-05-01,1.8800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2021,2021-05-01,0.2300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2021,2021-05-01,27.1100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2021,2021-05-01,41.8500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2021,2021-05-01,15.6500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2021,2021-05-01,9.8100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2021,2021-05-01,21.9000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2021,2021-04-01,1.4900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2021,2021-04-01,0.2600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2021,2021-04-01,23.4200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2021,2021-04-01,43.1700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2021,2021-04-01,14.6900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2021,2021-04-01,10.9500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2021,2021-04-01,20.3300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2021,2021-03-01,1.2900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2021,2021-03-01,0.1400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2021,2021-03-01,27.9100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2021,2021-03-01,48.0100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2021,2021-03-01,15.4300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2021,2021-03-01,11.7000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2021,2021-03-01,23.9400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2021,2021-02-01,2.5200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2021,2021-02-01,0.1300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2021,2021-02-01,31.1100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2021,2021-02-01,50.1400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2021,2021-02-01,14.6900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2021,2021-02-01,15.1700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2021,2021-02-01,24.1000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2021,2021-01-01,3.4100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2021,2021-01-01,0.0000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2021,2021-01-01,31.7400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2021,2021-01-01,46.3600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2021,2021-01-01,14.1300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2021,2021-01-01,13.8300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2021,2021-01-01,23.7900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2020,2020-12-01,4.1700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2020,2020-12-01,0.1200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2020,2020-12-01,29.4800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2020,2020-12-01,43.8900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2020,2020-12-01,13.2400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2020,2020-12-01,12.6900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2020,2020-12-01,20.6800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2020,2020-11-01,2.7700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2020,2020-11-01,0.3600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2020,2020-11-01,28.0800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2020,2020-11-01,42.3600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2020,2020-11-01,13.9500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2020,2020-11-01,12.4800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2020,2020-11-01,20.6700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2020,2020-10-01,2.4700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2020,2020-10-01,0.4500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2020,2020-10-01,28.2100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2020,2020-10-01,43.1600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2020,2020-10-01,13.8300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2020,2020-10-01,12.1600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,London,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2020,2020-10-01,19.7800,False
